Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: CD44-specific short peptide A6 boosts cellular uptake and anticancer efficacy of PEGylated liposomal doxorubicin in vitro and in vivo

Fig. 6

In vivo therapeutic efficacy of PLD and A6- PLD in mice bearing C-26 colon carcinoma tumor after i.v. administration of a single dose of 10 mg/kg liposomal doxorubicin or dextrose 5% on day 8 after tumor inoculation. A Tumor volume, B percentage change in animal body weight, C survival curve. Data represented as mean ± SE (n = 5)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us